Global brain health supplements market is estimated to be valued at US$ 9.0 Bn in 2023, and is expected tso exhibit a CAGR of 8.5% during the forecast period (2023-2030).
Analysts’ Views on Global Brain Health Supplements Market :
In preterm babies, increased energy and protein intake in the first month after birth is associated with improved head growth. Thus, increasing number of premature births, and increasing cases of child mortality will rise the demand for brain health supplements and this is expected to drive the global brain health supplements market growth over the forecast period. For instance, according to data published by the World Health Organization, on May 10, 2023, an estimated 13.4 million babies were born preterm in 2020. Preterm birth complications are the leading cause of death among children. The rate of preterm birth was nearly 4-16% of babies born in 2020.
Figure 1. Global Brain Health Supplements Market Share (%), By Application, 2023
To learn more about this report, Request sample copy
Global Brain Health Supplements Market – Driver
Figure 2. Global Brain Health Supplements Market Share (%), By Region, 2023
To learn more about this report, Request sample copy
Global Brain Health Supplements Market - Regional Analysis
Increasing use of brain health supplements is propelling the market growth during the forecast period. North America holds 40.3% of the market share. For instance, according to the 2021 AARP Brain Health and Dietary Supplement Survey,- a survey of adults with age 18 and older on their knowledge and use of vitamins. More than 25% of the U.S. population in the age group of 50 years and above were making use of supplements for their brain health. Also, 26% of the adult population takes at least one supplement for brain health, among these 21% take supplements for maintaining brain health, 20% for improving the brain health, 11% to delay the onset of dementia and around 8% of people take supplements to reverse the effect of dementia
Global Brain Health Supplements Market – Impact of Coronavirus (COVID-19) Pandemic
Since the COVID-19 virus outbreak in December 2019, the disease has spread to over 100 countries across the globe, and the World Health Organization declared it a public health emergency on January 30, 2020.
COVID-19 affected the economy in three main ways: by directly affecting the production and demand of drugs, by creating disruptions in distribution channels, and through its financial impact on firms and financial markets. Due to nationwide lockdowns, several countries such as China, India, Saudi Arabia, the U.A.E., Egypt, and others are facing problems with the transportation of drugs from one place to another.
However, the COVID-19 pandemic had a positive impact on the global brain health supplements market as students and health professionals needed special attention because of their higher psychological distress. Teachers and corporate employees reported mild levels of stress in lockdown. Moreover, the high risk of COVID-19 infection among geriatric patients can cause depression, fear and anxiety. This is expected to drive growth of the global brain supplements market during the forecast period.
Brain Health Supplements Market Report Coverage
Report Coverage | Details | ||
---|---|---|---|
Base Year: | 2022 | Market Size in 2023: | US$ 9.0 Bn |
Historical Data for: | 2018 to 2021 | Forecast Period: | 2023 to 2030 |
Forecast Period 2023 to 2030 CAGR: | 8.5% | 2030 Value Projection: | US$ 15.9 Bn |
Geographies covered: |
|
||
Segments covered: |
|
||
Companies covered: |
Alternascript, Accelerated Intelligence, Liquid Health, Health Via Modern Nutrition Inc., Natural Factors USA, Onnit Labs, Inc., Purelife bioscience Co., Ltd., Quincy Bioscience – The Makers of Prevagen, Cerebral success, Amway Corp., Puori, Ocean Health Pte Ltd., Schiff |
||
Growth Drivers: |
|
||
Restraints & Challenges: |
|
Uncover macros and micros vetted on 75+ parameters: Get instant access to report
Global Brain Health Supplements Market Segmentation:
The global brain health supplements market report is segmented into product type, application, supplement form, age group, distribution channel and region.
Global Brain Health Supplements Market Cross Sectional Analysis:
Among product type, the vitamins & minerals segment is expected to propel growth of the market in the North America during the forecast period due to increasing product launches in the region. In June 2020, Elysium Health, Inc.,- a U.S.-based manufacturer of dietary supplements, in collaboration with University Of Oxford- a collegiate research university in Oxford, England, launched Matter, a long-term brain health supplement. Matter contains a formulation of specific B vitamins that is clinically proven to slow brain atrophy associated with age-related memory loss. It also contains a powdered omega-3 lysine complex with enhanced bioavailability to optimize efficacy of the B-vitamin complex, and an anthocyanin-rich bilberry extract to provide complementary cognitive benefits.
Global Brain Health Supplements Market : Key Developments
Global Brain Health Supplements Market: Key Trends
Global Brain Health Supplements Market: Restraint
Global Brain Health Supplements Market - Key Players
Major players operating in the global brain health supplements market include Alternascript, Accelerated Intelligence, Liquid Health, Health Via Modern Nutrition Inc., Natural Factors USA, Onnit Labs, Inc., Purelife bioscience Co., Ltd., Quincy Bioscience – The Makers of Prevagen, Cerebral Success, Amway Corp., Puori, Ocean Health Pte Ltd., and Schiff
Global Brain Health Supplements Market – Definition
Brain supplements are natural dietary supplements that boost brain health and cognitive function. Brain supplements can offer a variety of health benefits including improved memory, concentration, focus, energy, mood, motivation, and long-term brain health. Natural components are used to create nootropics that enhance cognitive performance, and may even help a person’s long-term general brain health.
Share
About Author
Ghanshyam Shrivastava - With over 20 years of experience in the management consulting and research, Ghanshyam Shrivastava serves as a Principal Consultant, bringing extensive expertise in biologics and biosimilars. His primary expertise lies in areas such as market entry and expansion strategy, competitive intelligence, and strategic transformation across diversified portfolio of various drugs used for different therapeutic category and APIs. He excels at identifying key challenges faced by clients and providing robust solutions to enhance their strategic decision-making capabilities. His comprehensive understanding of the market ensures valuable contributions to research reports and business decisions.
Ghanshyam is a sought-after speaker at industry conferences and contributes to various publications on pharma industry.
Missing comfort of reading report in your local language? Find your preferred language :
Transform your Strategy with Exclusive Trending Reports :
Frequently Asked Questions
Select a License Type
Credibility and Certifications
860519526
9001:2015
27001:2022
Joining thousands of companies around the world committed to making the Excellent Business Solutions.
View All Our Clients